Literature DB >> 11093738

Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI.

C D Jolley1, J M Dietschy, S D Turley.   

Abstract

High density lipoprotein (HDL) cholesterol is believed to be preferentially utilized for bile acid synthesis and biliary secretion. In mice, the deletion of apolipoprotein AI (apo AI), the major apolipoprotein in HDL, results in very low plasma HDL-cholesterol levels. This article describes bile acid metabolism in apo AI-deficient (Apo AI(-/-)) mice and their C57BL/6 (Apo AI(+/+)) controls fed either a basal rodent diet alone or containing cholesterol or cholestyramine. Basal plasma HDL-cholesterol levels in the (-/-) mice (<10 mg/dL) were less than 20% of those in their (+/+) controls, but there were no phenotypic differences in either the relative cholesterol content of gallbladder bile, bile acid pool size and composition, fecal bile acid excretion or the activity of, or mRNA level for, cholesterol 7alpha-hydroxylase. However, compared with their (+/+) controls, the (-/-) mice absorbed more cholesterol (33 vs. 24%) and manifested lower rates of hepatic sterol synthesis (534 vs. 1,019 nmol/h per g). Cholesterol feeding increased hepatic cholesterol levels in the (+/+) animals from 2.7 to 4.4 mg/g and in the (-/-) mice from 2.6 to 8.1 mg/g. Bile acid synthesis increased 70% in both genotypes. Cholestyramine feeding stimulated bile acid synthesis 3.7 fold in both (-/-) and (+/+) mice. We conclude that the virtual loss of HDL-cholesterol from the circulation in apo AI deficiency has no impact on the ability of the hepatocyte to adapt its rate of bile acid synthesis in concert with the amount of cholesterol and bile acid returning to the liver from the small intestine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093738     DOI: 10.1053/jhep.2000.19811

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

Review 1.  From stool transplants to next-generation microbiota therapeutics.

Authors:  Elaine O Petrof; Alexander Khoruts
Journal:  Gastroenterology       Date:  2014-01-08       Impact factor: 22.682

2.  Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL.

Authors:  A K Groen; V W Bloks; R H Bandsma; R Ottenhoff; G Chimini; F Kuipers
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Intestinal Epithelial Sirtuin 1 Regulates Intestinal Inflammation During Aging in Mice by Altering the Intestinal Microbiota.

Authors:  Alicia S Wellman; Mallikarjuna R Metukuri; Nevzat Kazgan; Xiaojiang Xu; Qing Xu; Natalie S X Ren; Agnieszka Czopik; Michael T Shanahan; Ashley Kang; Willa Chen; M Andrea Azcarate-Peril; Ajay S Gulati; David C Fargo; Leonard Guarente; Xiaoling Li
Journal:  Gastroenterology       Date:  2017-05-26       Impact factor: 22.682

Review 4.  Biliary cholesterol secretion: more than a simple ABC.

Authors:  Arne Dikkers; Uwe-Jf Tietge
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

5.  Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™.

Authors:  Ayako Suzuki; Nancy A Yuen; Katarina Ilic; Richard T Miller; Melinda J Reese; H Roger Brown; Jeffrey I Ambroso; J Gregory Falls; Christine M Hunt
Journal:  Regul Toxicol Pharmacol       Date:  2015-05-16       Impact factor: 3.271

6.  Control of hypercholesterolemia and atherosclerosis using the cholesterol recognition/interaction amino acid sequence of the translocator protein TSPO.

Authors:  Laurent Lecanu; Zhi-Xing Yao; Althea McCourty; El-Khansa Sidahmed; Maria E Orellana; Miguel N Burnier; Vassilios Papadopoulos
Journal:  Steroids       Date:  2012-11-23       Impact factor: 2.668

7.  Male apoE*3-Leiden.CETP mice on high-fat high-cholesterol diet exhibit a biphasic dyslipidemic response, mimicking the changes in plasma lipids observed through life in men.

Authors:  Yared Paalvast; Albert Gerding; Yanan Wang; Vincent W Bloks; Theo H van Dijk; Rick Havinga; Ko Willems van Dijk; Patrick C N Rensen; Barbara M Bakker; Jan Albert Kuivenhoven; Albert K Groen
Journal:  Physiol Rep       Date:  2017-10-16

8.  Constitutive Androstane Receptor Differentially Regulates Bile Acid Homeostasis in Mouse Models of Intrahepatic Cholestasis.

Authors:  Kang Ho Kim; Jong Min Choi; Feng Li; Bingning Dong; Clavia Ruth Wooton-Kee; Armando Arizpe; Sayeepriyadarshini Anakk; Sung Yun Jung; Sean M Hartig; David D Moore
Journal:  Hepatol Commun       Date:  2018-12-04

9.  Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine.

Authors:  Rohit Singhal; Alison H Harrill; Francoise Menguy-Vacheron; Zaid Jayyosi; Hadj Benzerdjeb; Paul B Watkins
Journal:  BMC Pharmacol Toxicol       Date:  2014-08-03       Impact factor: 2.483

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.